A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)
Conditions: HPV16+ Squamous Cell Carcinoma Interventions: Drug: HB-200; Other: Placebo Sponsors: Memorial Sloan Kettering Cancer Center; Hookipa Biotech GmbH; Naveris Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Is the HIFEM Procedure an Effective Treatment for Men With Post-prostatectomy Incontinence?
Conditions: Prostate Cancer; Incontinence; Pelvic Floor Muscle Weakness Interventions: Device: HIFEM Sponsors: Kirsehir Ahi Evran Universitesi Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems
Conditions: Architectural Distortions; Breast Tomosynthesis Interventions: Device: Digital Breast Tomosynthesis (DBT) Sponsors: M.D. Anderson Cancer Center; Siemens Medical Solutions Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers
Discussion; Other: Interview; Other: Survey Administration Sponsors: University of Southern California; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Pre-pectoral Tissue Expander and Acellular Dermal Matrix for a Two-stage Muscle Sparing Breast Reconstruction
Conditions: Breast Cancer Interventions: Procedure: breast reconstruction Sponsors: Rossella Elia, MD PhD Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment
Conditions: Hematologic Malignancy; Treatment Adherence; Treatment Complication; Frailty; Quality of Life Interventions: Other: Comprehensive geriatric assessment (CGA) and treatment Sponsors: Odense University Hospital; Velux Fonden; Danish Cancer Research Foundation; The Dagmar Marshall Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Alternative Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers
Conditions: E-cigarette Use; Cigarette Smoking; Harm Reduction; Tobacco Use Interventions: Other: E-cigarettes; Other: Oral nicotine pouches Sponsors: University of Pennsylvania; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer
Conditions: Colorectal Cancer Interventions: Drug: SHR-8068; Drug: Adebrelimab; Drug: BP102 Sponsors: West China Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
The Effect of Foot Massage and Bed Bath on Individuals With Cancer
Conditions: Patients Interventions: Other: foot massage; Other: bed bath Sponsors: Saglik Bilimleri Universitesi Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Prediction of Therapeutic Response to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer Patients Using Spatial Transcriptomics
Conditions: Muscle-invasive Bladder Cancer Interventions: Other: neoadjuvant chemotherapy followed by radical cystectomy Sponsors: Yonsei University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer
Conditions: Anaplastic Thyroid Cancer Interventions: Drug: Pembrolizumab + Lenvatinib Sponsors: Saint Petersburg State University, Russia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
A Study of RO7617991 in Patients With Locally Advanced or Metastatic MAGE-A4-Positive Solid Tumors
Conditions: Refractory Cancer; Recurrent Cancer; Solid Tumor, Adult Interventions: Drug: RO7617991; Drug: Tocilizumab Sponsors: Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Metronomic Chemotherapy in a Real-world Population of Advanced Breast Cancer Patients
Conditions: Breast Cancer Interventions: Drug: cyclophosphamide , methotrexate , vinorelbine ,capecitabine Sponsors: Sun Yat-sen University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
BiVictriX Announces FDA Orphan Drug Designation and Completion of FDA INTERACT Meeting for BVX001 in the Treatment of Acute Myeloid Leukemia
Alderley Park, 17 April 2024– BiVictriX Therapeutics plc (AIM: BVX), a biotechnology company developing novel, next-generation bispecific Antibody Drug Conjugates (bxADCs) which are designed to offer substantially improved cancer cell... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 17, 2024 Category: Pharmaceuticals Source Type: clinical trials
U/S Guided Transversus Thoracic and Pectoral Nerve Block Versus Pectoral Nerve Block in MRM
Conditions: Breast Cancer; Analgesia Interventions: Procedure: Transeversus Thoracic Plane Block (TTPB) and Pectoral Nerves (PECS) Block; Procedure: Pectoral Nerves (PECS) Block Sponsors: Ahmed Mohamed Soliman Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
